🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

What's Next For Nike, More NCAA News, & Another New Football League

Published 03/26/2018, 02:49 AM
Updated 07/09/2023, 06:31 AM
ADSGN
-
CBS_old
-
NKE
-
FINL
-
FL
-
DKS
-
ADDYY
-

Welcome to the latest episode of the Full-Court Finance podcast from Zacks Investment Research. On this week’s episode, we dive into Nike’s (NYSE:NKE) recent quarterly results and begin to take a look at the company’s growth initiatives. We then transition to the latest financial news surrounding NCAA March Madness, as well as a discussion about NBA micro-transactions, and the recently announced Alliance of American Football.

Nike saw its North American revenues dip once again in Q3 as it faces further competition from rival sportswear power Adidas (OTC:ADDYY) . Shifting consumer habits have also led to lower sales at retail locations such as Dick’s Sporting Goods (NYSE:DKS) , Foot Locker (NYSE:FL) , and Finish Line (NASDAQ:FINL) .

However, in the long run, these challenges might have forced Nike to make changes to its business that could transform the company for the better.

Along with a detailed discussion about Nike, we dove into some of the money a long March Madness run can bring schools and coaches. The conversation then flows to some potentially game-changing news out of the NBA regarding its trial run of small, micro-payments for non-NBA League Pass customers.

This week’s episode ends with a look at another new football league that is set to debut in 2019, amid declining NFL ratings. The Alliance of American Football aims to capitalize on the NFL’s offseason and make some fan-friendly changes to the game.

Charlie Ebersol’s new football league, which looks like it will compete directly against Vince McMahon’s new XFL, will offer free live streaming on the league’s app as well as weekly games on CBS (NYSE:CBS) .

Make sure to listen to the whole podcast to hear everything you’ll need to know about the latest happenings in the sports business world.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



CBS Corporation (CBS): Free Stock Analysis Report

Foot Locker, Inc. (FL): Free Stock Analysis Report

The Finish Line, Inc. (FINL): Free Stock Analysis Report

DICK'S Sporting Goods, Inc. (DKS): Free Stock Analysis Report

NIKE, Inc. (NKE): Free Stock Analysis Report

Adidas AG (DE:ADSGN) (ADDYY): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.